FDA Grants Full Approval to Afami-Cel for Synovial Sarcoma and Expands Use to Adolescents
Jul 11, 2026
View online
FDA Grants Full Approval to Afami-Cel for Synovial Sarcoma and Expands Use to Adolescents
A Looming Collapse: Radiation Oncology’s Access Crisis Is No Longer Theoretical 2026
2026 IBRI Global Forum on Science, Philanthropy, and Investment
WHO Global Status Report on Cancer 2026: The Future We Choose Together
FDA Approves Subcutaneous Isatuximab for Multiple Myeloma
Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI
Asem Mansour։ CAR-T Therapy Manufacturing Advances in Jordan
Top Growing Medical Universities in Africa: 2026 Edition by BIGR
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
